Omar Saeed1, Shuaiqi Zhang2, Snehal R Patel3, Ulrich P Jorde3, Mario J Garcia3, Nurilign Bulcha4, Tanush Gupta5, Ying Xian2, Roland Matsouaka2, Shreyansh Shah6, Eric E Smith7, Lee H Schwamm8, Gregg C Fonarow9. 1. Division of Cardiology, Montefiore Medical Center, Albert Einstein College of Medicine, New York, NY. Electronic address: osaeed@montefiore.org. 2. Department of Neurology, Duke University School of Medicine, Raleigh, NC. 3. Division of Cardiology, Montefiore Medical Center, Albert Einstein College of Medicine, New York, NY. 4. Division of Cardiology, University of Pennsylvania Hospital Center, Philadelphia, PA. 5. Division of Cardiology, Columbia University Medical Center, New York, NY. 6. Duke Clinical Research Institute, Raleigh, NC. 7. Calgary Stroke Program, Department of Clinical Neurosciences, Hotchkiss Brain Institute, University of Calgary, Canada. 8. Department of Neurology, Massachusetts General Hospital, Boston, MA. 9. Division of Cardiology, University of California, Los Angeles, Los Angeles, CA.
Abstract
BACKGROUND: The safety and effectiveness of oral anticoagulation (OAC) after an ischemic stroke in older patients with heart failure (HF) without atrial fibrillation remains uncertain. METHODS: Utilizing Get With The Guidelines Stroke national clinical registry data linked to Medicare claims from 2009-2014, we assessed the outcomes of eligible patients with a history of HF who were initiated on OAC during a hospitalization for an acute ischemic stroke. The cumulative incidences of adverse events were calculated using Kaplan-Meier curves and adjusted Cox proportional hazard ratios were compared between patients discharged on or off OAC. RESULTS: A total of 8,261 patients from 1,370 sites were discharged alive after an acute ischemic stroke and met eligibility criteria. Of those, 747 (9.0%) were initiated on OAC. Patients on OAC were younger (77.2±8.0 vs. 80.5±8.9 years, p<0.01). After adjustment for clinical covariates, the likelihood of 1 year mortality was higher in those on OAC (aHR: 1.22, 95% CI 1.05-1.41, p<0.01), while no significant differences were noted for ICH (aHR: 1.34, 95% CI 0.69-2.59, p=0.38) and recurrent ischemic stroke (aHR: 0.78, 95% CI 0.54-1.15, p = 0.21). The likelihood of all-cause bleeding (aHR: 1.59, 95% CI 1.29-1.96, p<0.01) and all-cause re-hospitalization (aHR: 1.14, 95% CI 1.02-1.27, p = 0.02) was higher for those on OAC. CONCLUSION: Initiation of OAC after an ischemic stroke in older patients with HF in the absence of atrial fibrillation is associated with death, bleeding and re-hospitalization without an associated reduction in recurrent ischemic stroke. If validated, these findings raise caution for prescribing OAC to such patients.
BACKGROUND: The safety and effectiveness of oral anticoagulation (OAC) after an ischemic stroke in older patients with heart failure (HF) without atrial fibrillation remains uncertain. METHODS: Utilizing Get With The Guidelines Stroke national clinical registry data linked to Medicare claims from 2009-2014, we assessed the outcomes of eligible patients with a history of HF who were initiated on OAC during a hospitalization for an acute ischemic stroke. The cumulative incidences of adverse events were calculated using Kaplan-Meier curves and adjusted Cox proportional hazard ratios were compared between patients discharged on or off OAC. RESULTS: A total of 8,261 patients from 1,370 sites were discharged alive after an acute ischemic stroke and met eligibility criteria. Of those, 747 (9.0%) were initiated on OAC. Patients on OAC were younger (77.2±8.0 vs. 80.5±8.9 years, p<0.01). After adjustment for clinical covariates, the likelihood of 1 year mortality was higher in those on OAC (aHR: 1.22, 95% CI 1.05-1.41, p<0.01), while no significant differences were noted for ICH (aHR: 1.34, 95% CI 0.69-2.59, p=0.38) and recurrent ischemic stroke (aHR: 0.78, 95% CI 0.54-1.15, p = 0.21). The likelihood of all-cause bleeding (aHR: 1.59, 95% CI 1.29-1.96, p<0.01) and all-cause re-hospitalization (aHR: 1.14, 95% CI 1.02-1.27, p = 0.02) was higher for those on OAC. CONCLUSION: Initiation of OAC after an ischemic stroke in older patients with HF in the absence of atrial fibrillation is associated with death, bleeding and re-hospitalization without an associated reduction in recurrent ischemic stroke. If validated, these findings raise caution for prescribing OAC to such patients.
Authors: Gregg C Fonarow; Mathew J Reeves; Eric E Smith; Jeffrey L Saver; Xin Zhao; Dai Wai Olson; Adrian F Hernandez; Eric D Peterson; Lee H Schwamm Journal: Circ Cardiovasc Qual Outcomes Date: 2010-02-22
Authors: Muhammad Mamdani; Kathy Sykora; Ping Li; Sharon-Lise T Normand; David L Streiner; Peter C Austin; Paula A Rochon; Geoffrey M Anderson Journal: BMJ Date: 2005-04-23
Authors: Ying Xian; Gregg C Fonarow; Mathew J Reeves; Laura E Webb; Jason Blevins; Vladimir S Demyanenko; Xin Zhao; DaiWai M Olson; Adrian F Hernandez; Eric D Peterson; Lee H Schwamm; Eric E Smith Journal: Am Heart J Date: 2012-03 Impact factor: 4.749
Authors: Shunichi Homma; John L P Thompson; Patrick M Pullicino; Bruce Levin; Ronald S Freudenberger; John R Teerlink; Susan E Ammon; Susan Graham; Ralph L Sacco; Douglas L Mann; J P Mohr; Barry M Massie; Arthur J Labovitz; Stefan D Anker; Dirk J Lok; Piotr Ponikowski; Conrado J Estol; Gregory Y H Lip; Marco R Di Tullio; Alexandra R Sanford; Vilma Mejia; Andre P Gabriel; Mirna L del Valle; Richard Buchsbaum Journal: N Engl J Med Date: 2012-05-02 Impact factor: 91.245
Authors: Faiez Zannad; Stefan D Anker; William M Byra; John G F Cleland; Min Fu; Mihai Gheorghiade; Carolyn S P Lam; Mandeep R Mehra; James D Neaton; Christopher C Nessel; Theodore E Spiro; Dirk J van Veldhuisen; Barry Greenberg Journal: N Engl J Med Date: 2018-08-27 Impact factor: 91.245
Authors: Bradley G Hammill; Adrian F Hernandez; Eric D Peterson; Gregg C Fonarow; Kevin A Schulman; Lesley H Curtis Journal: Am Heart J Date: 2009-06 Impact factor: 4.749
Authors: Adrian F Hernandez; Xiaojuan Mi; Bradley G Hammill; Stephen C Hammill; Paul A Heidenreich; Frederick A Masoudi; Laura G Qualls; Eric D Peterson; Gregg C Fonarow; Lesley H Curtis Journal: JAMA Date: 2012-11-28 Impact factor: 56.272
Authors: Azmil H Abdul-Rahim; Ana-Cristina Perez; Rachael L MacIsaac; Pardeep S Jhund; Brian L Claggett; Peter E Carson; Michel Komajda; Robert S McKelvie; Michael R Zile; Karl Swedberg; Salim Yusuf; Marc A Pfeffer; Scott D Solomon; Gregory Y H Lip; Kennedy R Lees; John J V McMurray Journal: Eur Heart J Date: 2017-03-07 Impact factor: 29.983